XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Cash flows from operating activities:              
Net loss $ (108,161) $ 10,361 $ (22,156) $ (5,380) $ (84,812) $ (34,528)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation and amortization         2,397 1,984  
Inventory impairment charges 13   163   78 485  
Share-based compensation         14,185 0  
Amortization of discount and cost of issuance of debt         198 149  
Bad debts         125 74  
Non-cash interest expense         0 327  
(Gain) loss from change in fair value remeasurement of SAFEs 0   18,520   (21,600) 20,735  
(Gain) loss from change in fair value of warrants 40,401   0   29,085 0  
(Gain) loss from change in fair value of derivatives 45,516   0   27,677 0  
(Gain) loss from extinguishment of debt 0   0   (304) 0  
Deferred City Semi compensation         375 278  
Changes in operating assets and liabilities:              
Accounts receivable         (3,047) (471)  
Inventory         (2,730) 350  
Accounts payable         625 (1,755)  
Accrued expenses and other current liabilities         2,814 37  
Deferred revenue         (1,113) (2,139)  
Prepaid and other current assets         (2,848) 0  
Other long-term liabilities         782 (53)  
Net cash used in operating activities         (36,913) (14,527)  
Cash flows from investing activities:              
Purchases of property and equipment         (1,668) (625)  
Accrual for purchases of intangible assets         (784) 0  
Payments for acquired software license         0 (113)  
Business combination, net of cash         0 (38)  
Net cash used in investing activities         (2,452) (776)  
Cash flows from financing activities:              
Proceeds from issuance of SAFEs         5,000 15,250  
Proceeds from sale of noncontrolling interest         0 1,452  
Proceeds from issuance of debt obligations         155 4,973  
Proceeds from reverse recapitalization         377,663 0  
Issuance costs related to reverse recapitalization         (19,902) 0  
Payments on debt obligations         (15,008) (4,183)  
Payments on financed software         (2,270) (400)  
Redemption of Class H units         (900) 0  
Settlement of City Semi first tranche contingent consideration         (399) 0  
Net cash provided by financing activities         344,339 17,092  
Effect of exchange rate changes on cash and cash equivalents         193 21  
Net increase in cash and cash equivalents         305,167 1,810  
Cash and cash equivalents at beginning of period   $ 18,698   $ 7,155 18,698 7,155 $ 7,155
Cash and cash equivalents at end of period $ 323,865   $ 8,965   323,865 8,965 $ 18,698
Supplemental disclosure of cash flow information:              
Interest paid         1,188 1,121  
Supplemental disclosure of non-cash investing and financing activities:              
Purchases of property and equipment, accrued but not paid         206 3  
Conversion of historical members' equity         41,278 0  
Class G warrants cashless exchange         407 0  
Conversion of SAFEs         86,100 0  
Conversion of Embry Notes         4,119 0  
Recognition of earn-out considerations         119,759 0  
Recognition of warrant liabilities         74,408 0  
Accrual for purchases of intangible assets         12,198 64  
Earnout shares              
Adjustments to reconcile net loss to net cash used in operating activities:              
(Gain) loss from change in fair value of derivatives         27,677 0  
Currency forward contract              
Adjustments to reconcile net loss to net cash used in operating activities:              
(Gain) loss from change in fair value of derivatives         $ 1,200 $ 0